Investing.com - Addex Therapeutics (NASDAQ: ADXN) reported first quarter EPS of $-0.27, $0.22 worse than the analyst estimate of $-0.05. Revenue for the quarter came in at $564.55K versus the consensus estimate of $309.41K.
Addex Therapeutics's stock price closed at $0.94. It is down -35.62% in the last 3 months and down -76.50% in the last 12 months.
Addex Therapeutics saw positive EPS revisions and negative EPS revisions in the last 90 days. See Addex Therapeutics's stock price’s past reactions to earnings here.
According to InvestingPro, Addex Therapeutics's Financial Health score is "weak performance".
Check out Addex Therapeutics's recent earnings performance, and Addex Therapeutics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar